ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 309

Diagnostic Delay Of Even More Than 6 Months Contributes To Poor Radiographic and Functional Outcome In Psoriatic Arthritis

Muhammad Haroon1, Phil Gallagher2 and Oliver FitzGerald1, 1Department of Rheumatology, Dublin Academic Medical Centre, St. Vincent's University Hospital, Dublin, Ireland, 2Rheumatology, St. Vincent's University Hospital, Dublin, Ireland

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: diagnosis, physical impairment and psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment: Psoriatic Arthritis: Clinical Aspects and Treatment I

Session Type: Abstract Submissions (ACR)

Background/Purpose: Diagnostic delay in Psoriatic Arthritis (PsA) is not uncommon with a recent study of psoriasis patients attending a dermatology clinic showing that 29% of patients had undiagnosed PsA. Delay in diagnosis in turn delays introduction of appropriate disease-modifying treatment and may contribute to poor patient outcome. The objectives of this study were: 1) to investigate the demographic and clinical characteristics contributing to the delay from symptom onset to the first visit with a rheumatologist; 2) to compare clinical and radiographic features and patient-reported outcome measures in those who saw a rheumatologist early in their disease course compared to those who were diagnosed later, in a long-term follow-up cohort of PsA patients.

Methods: All PsA patients, fulfilling CASPAR criteria, with an average disease duration of >10 years were invited for detailed clinical evaluation. The total lag time from symptom onset to their first rheumatologic encounter was studied. All patients were interviewed in order to determine the date of symptom onset, defined as onset of stiffness, pain, or joint swelling, and the subsequent first visit to a rheumatologist,  dates which were further confirmed by data extracted from referral letters and medical records. Patients were classified as early consulters or late consulters depending on whether they were seen by a rheumatologist within or beyond 6 months of symptom onset. Following informed consent, patients underwent a detailed skin and rheumatologic assessment including disease activity measures.

Results: A total of 283 PsA patients [mean age 54.6±12 years; 52% female; mean PsA duration of 19±9 years] were studied. Median lag time from the disease onset to the first rheumatologic assessment of the cohort was 1.00 years (IQR 0.5-2). Thirty percent (n=86) of the cohort was seen by a rheumatologist within 6 months of the disease onset. Similarly, 53% (n=149) and 71% (n=202) of the cohort was reviewed within one and 2 years of the symptoms onset, respectively.  On univariate analysis,  late consulters (>6 months delay at first encounter), had significantly more erosions (OR 4.58, p=<0.001), osteolysis (OR 3.6, p=0.01), sacroiliitis (OR 2.28, p=0.01), arthritis mutilans (OR 10.6, p=0.02), deformed joints (OR 2.28, p=0.002), number of deformed joints (OR 1.06, p=0.006), more DMARDs/TNFi failures (OR 1.47, p=0.007), less patients achieving drug free remission (OR 0.42, p=0.01), and worse functional disability as reflected by the HAQ scores (OR 2.17, p=0.003). On multiple step-wise regression analysis, the model predicted significant association of late consulters with the development of peripheral joint erosions (OR 4.25, p=0.001), radiographic sacroiliitis (OR 1.47, p=0.09) and worse HAQ scores (OR 2.2, p=0.004). 

Conclusion: Even a 6 month delay from symptom onset to the first visit with a rheumatologist contributes to the development of peripheral joint erosions, sacroiliitis and worse long-term physical function.


Disclosure:

M. Haroon,
None;

P. Gallagher,
None;

O. FitzGerald,

Pfizer, Abbott, UCB, Roche, MSD, BMS,

2,

Janssen Pharmaceutica Product, Pfizer, Abbott, Roche, MSD, BMS,

5, 9,

Pfizer, Abbott, UCB, Roche, Janssen,

8.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/diagnostic-delay-of-even-more-than-6-months-contributes-to-poor-radiographic-and-functional-outcome-in-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology